Latest Articles
Niclosamide reduced signs of endometriosis in mice — ScienceAlert - UA.NEWS
Niclosamide reduced signs of endometriosis in mice — ScienceAlert UA.NEWS
Published: Oct. 4, 2026, 12:03 a.m.
Niclosamide reduced signs of endometriosis in mice — ScienceAlert - ua.news
Niclosamide reduced signs of endometriosis in mice — ScienceAlert ua.news
Published: Oct. 4, 2026, 12:03 a.m.
Tapeworm Drug Niclosamide Shrinks Endometriosis Lesions in Early Mouse Study - SSBCrack
Tapeworm Drug Niclosamide Shrinks Endometriosis Lesions in Early Mouse Study SSBCrack
Published: Oct. 3, 2026, 9:44 p.m.
Tapeworm Drug Niclosamide Shrinks Endometriosis Lesions in Early Mouse Study - news.ssbcrack.com
Tapeworm Drug Niclosamide Shrinks Endometriosis Lesions in Early Mouse Study news.ssbcrack.com
Published: Oct. 3, 2026, 9:44 p.m.
2-Deoxyglucose Dendrimer-Enabled Niclosamide Delivery to FRβ-Expressing Macrophages Alleviates Endometriosis Progression and Associated Hyperalgesia.
Endometriosis (EuE) is a chronic, incurable disease. Due to limited efficacy, high recurrence rates, and serious side effects of current treatments, development of new, targeted, nonhormonal therapies is urgently needed. …
Published: Aug. 30, 2026, midnight
2-Deoxyglucose dendrimer-enabled niclosamide delivery to FRβ-expressing macrophages alleviates endometriosis progression and associated hyperalgesia.
Endometriosis is a chronic, incurable disease. Due to limited efficacy, high recurrence rates, and serious side effects of current treatments, development of new, targeted, non-hormonal therapies is urgently needed. We …
Published: Feb. 12, 2026, midnight
The NLRP3 activation-related signature predicts the diagnosis and indicates immune characteristics in endometriosis.
Endometriosis (EMS) is a prevalent gynecological disease that leads to chronic pelvic pain and infertility in women of reproductive age. However, the underlying pathogenic genes and effective treatment for EMS …
Published: Jan. 31, 2025, midnight
Link copied to clipboard!